Early gene expression changes by Epstein-Barr virus infection of B-cells indicate CDKs and survivin as therapeutic targets for post-transplant lymphoproliferative diseases. [electronic resource]
Producer: 20140306Description: 2341-50 p. digitalISSN:- 1097-0215
- Apoptosis -- genetics
- B-Lymphocytes -- metabolism
- CDC2 Protein Kinase -- genetics
- Cell Cycle -- genetics
- Cyclin B1 -- genetics
- Epstein-Barr Virus Infections -- etiology
- Gene Expression
- Herpesvirus 4, Human
- Humans
- Inhibitor of Apoptosis Proteins -- genetics
- Leukocytes, Mononuclear -- metabolism
- Lymphoproliferative Disorders -- etiology
- Organ Transplantation -- adverse effects
- Survivin
- Transformation, Genetic
- Up-Regulation
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.